Literature DB >> 6470251

Computed tomography of malignant carcinoid disease.

S M McCarthy, D D Stark, A A Moss, H I Goldberg.   

Abstract

Twenty-two patients with malignant carcinoid syndrome were evaluated with CT, the largest series to date. A mass representing the primary tumor or local adenopathy was identified in four patients, appearing as a homogeneous mass involving mesentery and bowel. In two other patients the primary was not identifiable by barium series, angiography, CT, or laparotomy. In the remaining 16 patients who were scanned after resection of the primary four had mesenteric thickening and five had adenopathy. Malignant ascites was present in seven of 21 patients. All hepatic metastases were hypodense on the precontrast study. The effect of contrast administration on lesion detectability was variable, obscuring at least one or more metastases in eight of 21 scans. We recommend noncontrast scans of the liver in patients in whom the number and size of metastases are critical to therapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6470251     DOI: 10.1097/00004728-198410000-00006

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  6 in total

1.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.

Authors:  J K Ramage; A H G Davies; J Ardill; N Bax; M Caplin; A Grossman; R Hawkins; A M McNicol; N Reed; R Sutton; R Thakker; S Aylwin; D Breen; K Britton; K Buchanan; P Corrie; A Gillams; V Lewington; D McCance; K Meeran; A Watkinson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

2.  Diagnosis and categorization of small bowel neoplasms: role of computed tomography.

Authors:  F Laurent; M Raynaud; J M Biset; M Boisserie-Lacroix; P Grelet; J Drouillard
Journal:  Gastrointest Radiol       Date:  1991

3.  Scintigraphic detection of carcinoid tumors with a cost effectiveness analysis.

Authors:  Dimitris Dimitroulopoulos; Dimitris Xynopoulos; Klisthenis Tsamakidis; Emmanouel Paraskevas; Athanassios Zisimopoulos; Efthymios Andriotis; Ekaterini Fotopoulou; Marios Kontis; Ioannis Paraskevas
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

4.  Surgical treatment of mid-gut carcinoid tumors.

Authors:  C Makridis; K Oberg; C Juhlin; J Rastad; H Johansson; L E Lörelius; G Akerström
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

5.  Carcinoid of the appendix during laparoscopic cholecystectomy: unexpected benefits.

Authors:  M C DaSilva; R Haluck; R N Cooney; K E Minnick; F Ruggiero; J S Smith
Journal:  JSLS       Date:  1999 Jan-Mar       Impact factor: 2.172

6.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).

Authors:  John K Ramage; A Ahmed; J Ardill; N Bax; D J Breen; M E Caplin; P Corrie; J Davar; A H Davies; V Lewington; T Meyer; J Newell-Price; G Poston; N Reed; A Rockall; W Steward; R V Thakker; C Toubanakis; J Valle; C Verbeke; A B Grossman
Journal:  Gut       Date:  2011-11-03       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.